Taiwan FDA registration 3bb28d168c8ff19da47e6d1ff12b62b5
The new blood glucose tester set
TW: 暐世新型血糖測試儀套組
Taiwan·Risk Class 2·Hsinchu General Factory of Weishi Biotechnology Co., Ltd·Registered Jan 08, 2010 – Jan 08, 2030ActiveRegistration details
- Analysis ID
- 3bb28d168c8ff19da47e6d1ff12b62b5
- Customs Code
- DHY00500302309
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Hsinchu General Factory of Weishi Biotechnology Co., Ltd
Product details
- Intended Use
- This blood glucose tester is designed for diabetics and healthcare professionals, and uses whole blood collected from the fingertips to measure blood glucose concentration.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- Domestic
Dates and status
- Registration Date
- Jan 08, 2010
- Expiry Date
- Jan 08, 2030
About this record
Access comprehensive regulatory information for The new blood glucose tester set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3bb28d168c8ff19da47e6d1ff12b62b5 and manufactured by Hsinchu General Factory of Weishi Biotechnology Co., Ltd. The authorized representative in Taiwan is Hsinchu General Factory of Weishi Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices